{"companyId":272558,"requestedLanguage":"en","resolvedLanguage":"en","availableLanguages":["en","ja"],"companyName":"Dianthus Therapeutics, Inc.","headOfficeLocation":"New York, NY, United States","presidentName":"Marino Garcia","companySummary":null,"stockCode":"DNTH","currency":"USD","capital":null,"sales":null,"employees":null,"employeesConsolidated":null,"humanCheck":false,"domains":["dianthustx.com"],"businessContents":["Develops therapies for severe autoimmune diseases.","Develops clinical-stage monoclonal antibodies and fusion proteins."],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000169058526000006/dnth-20251231.htm","scoreAbout":500,"scoreBusiness":0,"scoreGroup":0,"scoreCustomer":0}]}